Array BioPharma, Inc. To Present At The Leerink Swann Global Healthcare Conference
BOULDER, Colo., Feb. 5, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: | Leerink Swann Healthcare Conference |
Presenter: | Ron Squarer, Chief Executive Officer |
Date: | Wednesday, February 11, 2015 |
Time: | 10:15 a.m. Eastern Time |
Location: | The Waldorf Astoria, New York, NY |
Webcast: | |
http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-EventDetails&EventId=5184603 |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-leerink-swann-global-healthcare-conference-300031621.html
SOURCE Array BioPharma Inc.